Latest Articles

Publication Date
Catheter-Directed Sclerotherapy Versus Ovarian Cystectomy for Unilateral Ovarian Endometrioma: A Pilot Randomized Controlled Trial.

Background: Ovarian cystectomy is standard treatment for endometrioma but is associated with decreased ovarian reserve. Catheter-directed sclerotherapy (CDS) is an ovary-sparing image-guided alternative; however, supporting evidence comprises retrospective comparative and …

Published: March 25, 2026, midnight
Women's Health Firms Aim for Earlier Endometriosis Diagnoses Through Menstrual Blood, Multiomics - GenomeWeb

Women's Health Firms Aim for Earlier Endometriosis Diagnoses Through Menstrual Blood, Multiomics GenomeWeb

Published: March 24, 2026, 6:12 p.m.
Absci forms advisory board for endometriosis drug program - Investing.com

Absci forms advisory board for endometriosis drug program Investing.com

Published: March 24, 2026, 12:23 p.m.
Local MP Suella Braverman hits out over trans charity role - Meon Valley Times

Local MP Suella Braverman hits out over trans charity role Meon Valley Times

Published: March 24, 2026, 9:35 a.m.
NEWS CENTER Maine at 11 PM - newscentermaine.com

NEWS CENTER Maine at 11 PM newscentermaine.com

Published: March 24, 2026, 3 a.m.
Endometrial epithelial cells with high ALDH activity control uterine development and regeneration.

Adult stem cells are thought to drive the regenerative potential of the endometrium and contribute to the pathogenesis of endometriosis, however, their identity and defining features remain to be characterized. …

Published: March 24, 2026, midnight
EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis - BioSpace

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis BioSpace

Published: March 23, 2026, 12:47 p.m.
EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis - PR Newswire

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis PR Newswire

Published: March 23, 2026, 11:30 a.m.
For years, Jo was told her pain was "normal". It took over her life. - The Australian Women's Weekly

For years, Jo was told her pain was "normal". It took over her life. The Australian Women's Weekly

Published: March 23, 2026, 6:27 a.m.
Aston University accredited as Endometriosis Friendly Employer - Greater Birmingham Chambers of Commerce

Aston University accredited as Endometriosis Friendly Employer Greater Birmingham Chambers of Commerce

Published: March 23, 2026, 4:55 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!